Oluwagbemiga A Ojo

4PUBLICATIONS
20CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 01, 2026
Extrafollicular and other non-germinal center B cell responses.

Stephanie C Eisenbarth, K Maude Ashby, Oluwagbemiga A Ojo

|May 15, 2025
Gfi1 controls the formation of effector-like CD8+ T cells during chronic infection and cancer.

Oluwagbemiga A Ojo, Hongxing Shen, Jennifer T Ingram

|Feb 12, 2025
PTP Inhibition Improves the Macrophage Antitumor Immune Response and the Efficacy of Chemo- and Radiotherapy.

Nestor Prieto-Dominguez, Paran Goel, Oluwagbemiga A Ojo

|Oct 31, 2024
HIF1α-regulated glycolysis promotes activation-induced cell death and IFN-γ induction in hypoxic T cells.

Hongxing Shen, Oluwagbemiga A Ojo, Haitao Ding

Pageof 1